Form 8-K - Current report:
SEC Accession No. 0001213900-21-004031
Filing Date
2021-01-25
Accepted
2021-01-25 16:03:05
Documents
1
Period of Report
2021-01-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133876-8k_inmunebio.htm 8-K 29437
  Complete submission text file 0001213900-21-004031.txt   30630
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 21549664
SIC: 2836 Biological Products, (No Diagnostic Substances)